Food and Drug Administration, Center for Drug Evaluation and Research. FDA drug safety communication: update to ongoing safety review of Actos (pioglitazone) and increased risk of bladder cancer (6/15/2011). FDA Web site. Available at: http://www.fda.gov/Drugs/DrugSafety/ucm259150.htm. Accessed July 29, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click